Tudor Investment Corp’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Tudor Investment Corp's ADPT Position: Q2 2026 in Review
Tudor Investment Corp reduced its Adaptive Biotechnologies (ADPT) stake by 31% in Q2 2026, selling an estimated $3.72M and leaving 543,485 shares worth $11.7M. The position accounts for 0.02% of the portfolio, ranked #747.
Tudor Investment Corp first reported a position in ADPT in Q2 2019 and has held it in 16 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Tudor Investment Corp held 543,485 shares of Adaptive Biotechnologies worth $11.7M as of Q2 2026.
- Tudor Investment Corp sold 242,796 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.72M.
- Adaptive Biotechnologies made up 0.02% of Tudor Investment Corp's portfolio in Q2 2026, its #747 holding.
- Tudor Investment Corp first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 16 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.